当前位置： SCI文献检索 > CLINICAL NUCLEAR MEDICINE期刊下所有文献 > Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy.

Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy.

Abstract：

BACKGROUND AND AIM:Papillary thyroid carcinomas smaller than 1 cm are classified as papillary microcarcinomas (PMCs). Papillary microcarcinomas are usually considered low-risk tumors; however in some cases, PMCs behave aggressively and metastasize early, giving rise to clinically metastatic disease. Debate exists in the literature about prognostic factors and therapeutic management to PMC. We report here the long-term experience of our referral center for malignant thyroid disease. METHODS:We retrospectively analyzed 149 consecutive patients with PMC who underwent surgery at our institution between 2000 and 2005; 49 of them (33% of cases) were treated also with radioiodine therapy. Clinical and histopathological parameters potentially predicting patient outcome and recurrent disease were statistically investigated, after a minimum follow-up of 5 years. RESULTS:After a median follow-up of 5.4 years (range, 5-11 years), 28 (19%) of 149 patients experienced recurrent disease. All of them were reoperated on and newly treated with radioiodine administration. Of these 28 patients, 27 are living without disease, whereas 1 patient died due to metastatic thyroid cancer to lungs. The multivariate statistical analysis identified extrathyroid invasion (odds ratio [OR], 58.54; P=0.013), the solid pattern (OR, 25.77; P<0.001), the tumor multifocality (OR, 15.80; P=0.005), and the absence of tumor capsule (OR, 9.74; P=0.015) as significant and independent risk factors for the appearance of PMC recurrences. Of note, in most patients who experienced recurrent disease, the PMC had been diagnosed preoperatively and often for the presence of cervical clinically evident lymphadenopathy. On the other hand, none of the PMC "incidentally" discovered at histopathological examination alone experienced recurrent disease during follow-up. CONCLUSIONS:Although most PMCs have an indolent course, there is a fraction (19% in our series) of patients with PMC and aggressive behavior strongly correlated with some histopathological features (extrathyroid invasion, solid pattern, tumor multifocality, and absence of a capsule) who need to be individualized and for whom a radical therapeutic approach is recommended based on total thyroidectomy and lymphadenectomy followed by radioiodine administration.

journal_name

Clin Nucl Med

journal_title

Clinical nuclear medicine

authors

Ardito G,Revelli L,Giustozzi E,Salvatori M,Fadda G,Ardito F,Avenia N,Ferretti A,Rampin L,Chondrogiannis S,Colletti PM,Rubello D

doi

10.1097/RLU.0b013e318279bc65

subject

Has Abstract

pub_date

2013-01-01 00:00:00

pages

25-8

issue

eissn

0363-9762

issn

1536-0229

pii

00003072-201301000-00005

journal_volume

pub_type

杂志文章

在线工具

Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy.